Abstract: An analyzing method using an analyzer including a wavelength-dispersive X-ray spectrometer that has an analyzing element to analyze an X-ray emitted from a specimen and detects an X-ray of energy corresponding to a position of the analyzing element. The analyzing method includes acquiring a plurality of map data by repeatedly performing a mapping analysis while changing the position of the analyzing element, the mapping analysis being an analysis to detect an X-ray of specific energy with the position of the analyzing element fixed to acquire map data while scanning the specimen with an electron beam; and generating, based on the plurality of map data, a spectrum map in which a position on the specimen and an X-ray spectrum are associated with each other.

Abstract: In one aspect, an improved craps system may comprise at least one camera and a dealer station having at least one dealer station memory, at least one dealer station display device, and at least one dealer station processor in communication with the at least one camera. The at least one dealer station processor may be configured to receive the information from the camera regarding the throw of dice and determine, based upon the information, whether the throw complies with one or more requirements for a proper throw of dice.

Abstract: Provided is a pharmaceutical preparation including a polymerized camptothecin derivative that is obtained by bonding a camptothecin derivative having nanoparticle-forming properties by associating in an aqueous solution, to a polymer carrier, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties and camptothecin derivative bonding stability, which are important factors, and having excellent storage stability is provided. Disclosed is a pharmaceutical preparation including a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment including a glutamic acid unit having a camptothecin derivative bonded thereto; and a saccharide.

Abstract: Provided is a pharmaceutical preparation including a polymerized camptothecin derivative obtained by bonding a camptothecin derivative to a polymer carrier, the polymerized camptothecin derivative being capable of associating in an aqueous solution and having a nanoparticle-forming property, and the pharmaceutical preparation is a pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation having an excellent associated aggregate-forming property, which is an important factor, and excellent storage stability against chemical stability is provided. Disclosed is a pharmaceutical preparation including a block copolymer in which a polyethylene glycol segment and a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, and a pharmaceutical preparation including one or more additives selected from the group consisting of arginine, histidine, and sodium chloride.

Abstract: Provided is a pharmaceutical preparation including a polymerized camptothecin derivative that is obtained by bonding a camptothecin derivative having nanoparticle-forming properties by associating in an aqueous solution, to a polymer carrier, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties and camptothecin derivative bonding stability, which are important factors, and having excellent storage stability is provided. Disclosed is a pharmaceutical preparation including a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment including a glutamic acid unit having a camptothecin derivative bonded thereto; and a saccharide.

Abstract: Provided is a pharmaceutical preparation composition comprising a polymerized camptothecin derivative which is obtained by bonding a camptothecin derivative to a polymer carrier, and has nanoparticle-forming properties of associating in an aqueous solution, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties, which are an important factor, and having an excellent storage stability is provided. Disclosed is a pharmaceutical preparation comprising a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, the pharmaceutical preparation capable of forming associates in an aqueous solution. When the pharmaceutical preparation is made into an aqueous solution containing the camptothecin derivative at a concentration of 1 mg/mL, the pH of the aqueous solution is 2.4 to 7.

Abstract: Provided is a pharmaceutical preparation composition comprising a polymerized camptothecin derivative which is obtained by bonding a camptothecin derivative to a polymer carrier, and has nanoparticle-forming properties of associating in an aqueous solution, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties, which are an important factor, and having an excellent storage stability is provided. Disclosed is a pharmaceutical preparation comprising a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, the pharmaceutical preparation capable of forming associates in an aqueous solution. When the pharmaceutical preparation is made into an aqueous solution containing the camptothecin derivative at a concentration of 1 mg/mL, the pH of the aqueous solution is 2.4 to 7.

Abstract: A scatter diagram display device includes a principal component analysis section that performs principal component analysis on intensity or concentration map data that represents each element, a priority level setting section that sets a priority level to each element based on the results of the principal component analysis performed by the principal component analysis section, and a display control section that performs a control process that arranges a plurality of scatter diagrams generated by combining each element based on the priority level that has been set to each element by the priority level setting section, and displays the plurality of scatter diagrams on a display section.

Abstract: Provided is a pharmaceutical preparation composition comprising a polymerized camptothecin derivative which is obtained by bonding a camptothecin derivative to a polymer carrier, and has nanoparticle-forming properties of associating in an aqueous solution, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties, which are an important factor, and having an excellent storage stability is provided. Disclosed is a pharmaceutical preparation comprising a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, the pharmaceutical preparation capable of forming associates in an aqueous solution. When the pharmaceutical preparation is made into an aqueous solution containing the camptothecin derivative at a concentration of 1 mg/mL, the pH of the aqueous solution is 2.4 to 7.

Abstract: Provided is a pharmaceutical preparation composition comprising a polymerized camptothecin derivative which is obtained by bonding a camptothecin derivative to a polymer carrier, and has nanoparticle-forming properties of associating in an aqueous solution, the pharmaceutical preparation composition having enhanced preparation stability. Particularly, a pharmaceutical preparation maintaining nanoparticle-forming properties, which are an important factor, and having an excellent storage stability is provided. Disclosed is a pharmaceutical preparation comprising a block copolymer in which a polyethylene glycol segment is linked to a polyglutamic acid segment containing a glutamic acid unit having a camptothecin derivative bonded thereto, the pharmaceutical preparation capable of forming associates in an aqueous solution. When the pharmaceutical preparation is made into an aqueous solution containing the camptothecin derivative at a concentration of 1 mg/mL, the pH of the aqueous solution is 2.4 to 7.

Abstract: A phase analyzer includes a principal component analysis section that performs principal component analysis on elemental map data that represents an intensity or concentration distribution corresponding to each element to calculate a principal component score corresponding to each unit area of the elemental map data, a scatter diagram generation section that plots the calculated principal component score to generate a scatter diagram of the principal component score, a peak position detection section that detects a peak position from the scatter diagram, a clustering section that calculates a distance between each point and each peak position within the scatter diagram, and classifies each point within the scatter diagram into a plurality of groups based on the distance, and a phase map generation section that generates a phase map based on classification results of the clustering section.

Abstract: A scatter diagram display device includes a principal component analysis section that performs principal component analysis on intensity or concentration map data that represents each element, a priority level setting section that sets a priority level to each element based on the results of the principal component analysis performed by the principal component analysis section, and a display control section that performs a control process that arranges a plurality of scatter diagrams generated by combining each element based on the priority level that has been set to each element by the priority level setting section, and displays the plurality of scatter diagrams on a display section.

Abstract: A phase analyzer includes a principal component analysis section that performs principal component analysis on elemental map data that represents an intensity or concentration distribution corresponding to each element to calculate a principal component score corresponding to each unit area of the elemental map data, a scatter diagram generation section that plots the calculated principal component score to generate a scatter diagram of the principal component score, a peak position detection section that detects a peak position from the scatter diagram, a clustering section that calculates a distance between each point and each peak position within the scatter diagram, and classifies each point within the scatter diagram into a plurality of groups based on the distance, and a phase map generation section that generates a phase map based on classification results of the clustering section.

Abstract: A male connector (M) has male housings (20A, 20B, 20C) and is connectable with a female connector (F) with female housings (40A, 40B, 40C). Error connection preventing projections (28A, 28B) of the male housings (20A, 20B) are received in receiving portions (47A, 47B) of the female housings (40A, 40B) to connect the two connectors (M, F) properly if the combination of the housings in the male and female connectors (M, F) is correct. However, the error connection preventing projections (28A, 28B) on the male housings (20A, 20B) interfere with opposed the female housings (40B, 40C) and hinder connection of the two connectors (M, F) if the combination of housings is incorrect.

Abstract: A wavelength dispersion probing system for determining a value of wavelength dispersion and its sign and reducing the trouble and time required for this determination. This wavelength dispersion probing system comprises light sources 10, 12, light attenuators 14, 16, optical multiplexer 18, phase modulator 20, optical amplifiers 22, 26, acoustooptical modulator 24, optical receiver 30. The intensity ratio of two wavelengths is set at 1 to 2 to detect Stokes light or anti-Stokes light included in the return light of an optical fiber 100 by the optical receiver 30, so that wavelength dispersion is probed. The wavelength dispersion is probed by changing the intensity ratio of the two wavelengths to observe the state of the change of the wavelength dispersion, so that the sign of wavelength dispersion is determined by the optical receiver 30.

Abstract: A male terminal fitting (10) provided with a tab (11) is insertable into an auxiliary housing (20) from behind. A protection cap (30) capable of protecting the tab (11) by surrounding it is mounted on the auxiliary housing (20), thereby constructing a cap-fitted auxiliary connector (SC). The protection cap (30) is provided with front-stops (36) for holding the male terminal fitting (10) at its proper insertion position so as not move any further forward by being engaged with the male terminal fitting (10) inserted into the auxiliary housing (20).

Abstract: A female housing (10) has cavities (11) for receiving female terminal fittings (30). A lock (13) is provided in each cavity (11) and is deformed by insertion of the female terminal fitting (30). However the lock (13) is restored resiliently to engage and lock the female terminal fitting (30) in the cavity (11). Maneuverable recesses (24) are provided on the front surface of each lock (13) retracted from the locked terminal fitting (30). A disengagement jig (60) can be engaged with the maneuverable recesses (24) to deflect the lock (13) so that the terminal fitting (30) can be removed from the cavity (11).

Abstract: A female connector (F) has female terminal fittings (10), female auxiliary housings (20) for accommodating the female terminal fittings (10), and a female frame for accommodating the female auxiliary housings (20). A male connector (M) has male terminal fittings (40) with tabs (41), male auxiliary housings (50) for accommodating the male terminal fittings (40), and a male frame (60) with a receptacle (61) for accommodating the male auxiliary housings (50) and into which the female connector (F) is fittable. A moving plate (70) is movable backward in the receptacle and has positioning holes (73) into which the tabs (41) are introduced. The moving plate (70) has positioning projections (80), and the female auxiliary housings (20) has positioning recesses (81) engageable with the positioning projections (80). Thus, the moving plate (70) and the female auxiliary housings (20) can be positioned with respect to each other.

Abstract: A wavelength dispersion probing system for determining a value of wavelength dispersion and its sign and reducing the trouble and time required for this determination. This wavelength dispersion probing system comprises light sources 10, 12, light attenuators 14, 16, optical multiplexer 18, phase modulator 20, optical amplifiers 22, 26, acoustooptical modulator 24, optical receiver 30. The intensity ratio of two wavelengths is set at 1 to 2 to detect Stalk light or anti-Stalk light included in the return light of an optical fiber 100 by the optical receiver 30, so that wavelength dispersion is probed. The wavelength dispersion is probed by changing the intensity ratio of the two wavelengths to observe the state of the change of the wavelength dispersion, so that the sign of wavelength dispersion is determined by the optical receiver 30.

Abstract: A female housing (10) has cavities (11) for receiving female terminal fittings (30). A lock (13) is provided in each cavity (11) and is deformed by insertion of the female terminal fitting (30). However the lock (13) is restored resiliently to engage and lock the female terminal fitting (30) in the cavity (11). Maneuverable recesses (24) are provided on the front surface of each lock (13) retracted from the locked terminal fitting (30). A disengagement jig (60) can be engaged with the maneuverable recesses (24) to deflect the lock (13) so that the terminal fitting (30) can be removed from the cavity (11).